Abstracts tagged "bacterial infections and oral"

Abstract Number: 517 • 2013 ACR/ARHP Annual Meeting
Antibody Responses To Oral Bacteria In Patients With Primary Sjögren’s Syndrome and Comparison With Rheumatoid Arthritis and Periodontitis
Bozo Lugonja¹, Michael Milward², Diana Pearson³, Thomas Dietrich⁴, Iain Chapple⁵, John Hamburger⁶, Francesca Barone¹, Saaeha Rauz⁷, Lorraine Yeo⁸, Ana Povedo-Gallego⁹, Geraint Williams⁷, Paola de Pablo¹, Andrea Richards⁹, Christopher D. Buckley¹, Dagmar Scheel-Toellner⁸ and Simon J. Bowman¹⁰, ¹Rheumatology Research Group, University of Birmingham Research Laboratories, University of Birmingham, Birmingham, United Kingdom, ²Dept of Periodontology, University of Birmingham, Birmingham, United Kingdom, ³Dept of Periodontology, Birmingham Dental Hospital, Birmingham, United Kingdom, ⁴School of Dentistry, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁵Periodontology Dept, School of Dentistry, University of Birmingham, Birmingham, United Kingdom, ⁶Dept of Oral Medicine, School of Dentistry, University of Birmingham, Birmingham, United Kingdom, ⁷Academic Unit of Ophthalmology, University of Birmingham, Birmingham, United Kingdom, ⁸Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK, Birmingham, United Kingdom, ⁹Dept of Oral Medicine, Birmingham Dental Hospital, Birmingham, United Kingdom, ¹⁰Department of Rheumatology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Background/Purpose: We set out to examine peripheral blood antibody ELISA responses to common oral bacteria in primary Sjögren’s syndrome (pSS) to identify potential bacterial triggers…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].